Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Argus Health
Boehringer Ingelheim
Express Scripts
Accenture
Chinese Patent Office
Moodys
Merck
UBS

Generated: December 13, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER

« Back to Dashboard

Clinical Trials for Ritodrine Hydrochloride In Dextrose 5% In Plastic Container

Trial ID Title Status Sponsor Phase Summary
NCT00137501 Two Dose Regimens of Nifedipine for the Management of Preterm Labor Terminated American University of Beirut Medical Center Phase 3 Preterm birth is one of the most important causes of perinatal morbidity and mortality worldwide. Prevention and treatment of preterm labor is important, not as an end in itself, but as a means of reducing adverse events for the neonate. A wide range of tocolytics, drugs used to suppress uterine contractions, have been tried. Magnesium sulfate (MgSO4) is the most widely used tocolytic at the American University of Beirut Medical Center despite the fact that an effective tocolytic role of MgSO4 has never been established. Moreover, the currently available data are suggestive of deleterious fetal effects of MgSO4 in the setting of preterm labor to the extent that some authorities are recommending abandoning it for routine use as a tocolytic therapy. Calcium channel blockers have the ability to inhibit contractility in smooth muscle cells. Consequently, nifedipine has emerged as an effective and rather safe alternative tocolytic agent for the management of preterm labor after several studies have shown that the use of nifedipine in comparison with other tocolytics is associated with a more frequent successful prolongation of pregnancy, resulting in significantly fewer admissions of newborns to the neonatal intensive care unit, and is associated with a lower incidence of respiratory distress syndrome. The unequivocal impact of this method of tocolysis on short term postponement of delivery and the opportunity that this provides for affecting in-utero transfer and steroid administration has prompted many investigators to recommend focusing future trials on testing different dose regimens of nifedipine. To the best of the investigators' knowledge, no study comparing two different dose regimens of nifedipine has been previously published in the literature. The objective of their study is to compare the effectiveness of a high versus a low dose regimen in a total of 200 patients admitted with the diagnosis of preterm labor between 24 and 34 weeks of gestation. In addition, the investigators' study will try to assess the safety profile of the 2 dose regimens on the mother and the neonate by assessing a selected number of outcome variables. The data generated will be used to change their protocol for managing patients presenting with threatened preterm delivery and will fill the existing gap regarding the most effective and safest dose regimen of nifedipine in such patients.
NCT00290173 Ritodrine in Oral Maintenance of Tocolysis After Active Preterm Labor Completed Ministry of Science, Education and Sport, Republic of Croatia N/A This is a trial comparing the efficacy of oral ritodrine in the form of sustained release capsules for the maintenance of uterine quiescence after successfully treated episode of threatened preterm labor.
NCT00290173 Ritodrine in Oral Maintenance of Tocolysis After Active Preterm Labor Completed University of Zagreb N/A This is a trial comparing the efficacy of oral ritodrine in the form of sustained release capsules for the maintenance of uterine quiescence after successfully treated episode of threatened preterm labor.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Ritodrine Hydrochloride In Dextrose 5% In Plastic Container

Condition Name

Condition Name for Ritodrine Hydrochloride In Dextrose 5% In Plastic Container
Intervention Trials
Neonatal Respiratory Distress 1
Labor, Premature 1
Preterm Labour 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Ritodrine Hydrochloride In Dextrose 5% In Plastic Container
Intervention Trials
Obstetric Labor, Premature 6
Premature Birth 3
Respiratory Distress Syndrome, Newborn 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Ritodrine Hydrochloride In Dextrose 5% In Plastic Container

Trials by Country

Trials by Country for Ritodrine Hydrochloride In Dextrose 5% In Plastic Container
Location Trials
Egypt 2
Croatia 1
United States 1
Lebanon 1
United Arab Emirates 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Ritodrine Hydrochloride In Dextrose 5% In Plastic Container
Location Trials
New York 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Ritodrine Hydrochloride In Dextrose 5% In Plastic Container

Clinical Trial Phase

Clinical Trial Phase for Ritodrine Hydrochloride In Dextrose 5% In Plastic Container
Clinical Trial Phase Trials
Phase 4 1
Phase 3 2
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Ritodrine Hydrochloride In Dextrose 5% In Plastic Container
Clinical Trial Phase Trials
Recruiting 3
Completed 3
Terminated 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Ritodrine Hydrochloride In Dextrose 5% In Plastic Container

Sponsor Name

Sponsor Name for Ritodrine Hydrochloride In Dextrose 5% In Plastic Container
Sponsor Trials
Assiut University 3
University of Zagreb 1
Ministry of Science, Education and Sport, Republic of Croatia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Ritodrine Hydrochloride In Dextrose 5% In Plastic Container
Sponsor Trials
Other 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Fish and Richardson
Johnson and Johnson
Cerilliant
Dow
Cantor Fitzgerald
QuintilesIMS
Merck
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.